Related Experiment Video
Updated: Aug 24, 2026
Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
Malignant gliomas
Patrick Y Wen1, Santosh Kesari
1Center for Neuro-Oncology, Dana Farber Cancer Institute, SW430D, 44 Binney Street, Boston, MA 02115, USA. pwen@partners.org
Abstract:
Malignant gliomas are the most common type of primary brain tumor. Although therapy for patients with these tumors remains limited, there has been important progress recently. In this review, some of these advances are discussed, with an emphasis on targeted molecular therapies.
Insights
Malignant gliomas, common brain tumors, have limited treatment options. Recent advances focus on targeted molecular therapies, offering new hope for patients.
Area of Science:
- Neuro-oncology
- Molecular biology
- Cancer therapy
Background:
- Malignant gliomas represent the most frequent primary brain tumors.
- Current therapeutic strategies for malignant gliomas exhibit limitations.
- Recent scientific progress has been made in understanding and treating these tumors.
Purpose of the Study:
- To review recent advances in the therapy of malignant gliomas.
- To highlight the role and progress of targeted molecular therapies.
Main Methods:
- Literature review of recent studies on malignant glioma treatment.
- Focus on targeted molecular therapies and their clinical implications.
Main Results:
- Discussion of emerging therapeutic strategies for malignant gliomas.
- Emphasis on advancements in targeted molecular therapies.
Conclusions:
- Targeted molecular therapies represent a promising frontier in malignant glioma treatment.
- Continued research is crucial for improving patient outcomes in neuro-oncology.
